Meet the developers behind the Pfizer building conversion
New York City turned its eyes towards the former Pfizer building in Midtown East Tuesday morning, but not for the reason the developers would’ve hoped. Reports emerged before 8 a.m. of debris falling from the construction site at 235 East 42nd Street, arguably the country’s most notable office-to-residential conversion post-pandemic to unfold. As of midday, concerns about the safety of the building remain as columns within the building buckle, forcing evacuations and street closures in and around the property. It’s not the first notable incident at the project, which commanded real estate’s attention long before pedestrians were forced to steer […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts
“Freak accident”: Pfizer building developer denies risk of
collapse
Deal Diary: The $80K Deal That Turned Into a 24-Unit
Building
Policy Pro: HPD floats 421a rule change to keep more
projects alive
NYCHA plumber’s $465K payday sparks probe into outside
work
Michael Shabsels lists Westhampton home for $75K a
month
Buckling ex-Pfizer HQ hit with multiple DOB violations last
year
Namdar Group grabs additional financing in Jersey
City
Prana Investments’ NYC multifamily portfolio faces 14
foreclosure lawsuits
Vacant rent-stabilized apartment rate climbs despite
persistent housing shortage
